San Carlos, CA, April 13, 2020 – FlemingMartin is pleased to announce that Natera (NASDAQ: NTRA), a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease, has hired Jim Martineau as Head of Oncology Product Management.
Jim will hold ownership of the oncology product roadmap, provide product definition, management, strategic prioritization, technical leadership, and strategic vision for Natera’s current oncology products as well as future pipeline products.
Jim comes to Natera after four years with Flatiron Health (acquired by Roche in 2018). At Flatiron, Jim served as the Director of Product and Operations for the Academics & Health Systems enterprise business line, holding responsibility for product strategy, budgeting, roadmap, product execution, and operations. In this position, Jim concepted, built, and launched a suite of enterprise real world data products that serviced Flatiron’s network of academic, health system, and community cancer centers.
Jim received his MBA in Health Care Management & Entrepreneurship from The Wharton School at the University of Pennsylvania. He earned his MS in Computational & Mathematical Engineering from Stanford University and his BS in Engineering Physics from the Colorado School of Mines.
Natera is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Natera’s Signatera technology is the first and only circulating tumor DNA (ctDNA) surveillance tool that detects molecular residual disease (MRD) for greater clinical confidence when assessing disease recurrence or treatment response in solid tumors. To learn more, visit natera.com.
FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, Private Equity Firms, and CEOs of companies to build successful execution-focused management teams. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital. flemingmartin.com